Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
about
Has sclerostin a true endocrine metabolic action complementary to osteocalcin in older men?Empagliflozin and linagliptin combination therapy for treatment of patients with type 2 diabetes mellitus.Normal bone density and trabecular bone score, but high serum sclerostin in congenital generalized lipodystrophy.Novel bone metabolism-associated hormones: the importance of the pre-analytical phase for understanding their physiological roles.Effects of Type 1 Diabetes on Osteoblasts, Osteocytes, and Osteoclasts.Bone-Derived Factors: A New Gateway to Regulate Glycemia.Hormonal and systemic regulation of sclerostin.Bone Cell Bioenergetics and Skeletal Energy Homeostasis.Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.Relationships between Bone Turnover and Energy Metabolism.The association between sclerostin and incident type 2 diabetes risk: a cohort study.Sclerostin influences body composition by regulating catabolic and anabolic metabolism in adipocytes.The potential role of the osteopontin-osteocalcin-osteoprotegerin triad in the pathogenesis of prediabetes in humans.The relationship between postmenopausal women's sclerostin levels and their bone density, age, body mass index, hormonal status, and smoking and consumption of coffee and dairy products.Circulating levels of sclerostin are associated with cardiovascular mortality.
P2860
Q35967442-D5A48122-1CAC-4639-BD2D-3189BFAC084BQ38638523-16A607F4-69E8-42FA-B130-F42EDBA02269Q38846381-1431C300-BB06-4AD1-BBB8-AF803DF37FC7Q38970563-F9BBCED2-7EA8-4C32-875C-261A5695FD68Q38972516-2CE7E4A3-1F50-44F6-9858-68E5A6D0FBC1Q39004609-12B53008-15CC-42DD-8A3B-5D752A3F26AAQ39037907-0C27D59E-F46C-425B-B43F-A0CAC9E25A41Q39137277-C3BFEE6C-EA23-40D7-A898-0E6D401DA5C4Q39242378-B61D96D4-D425-41B5-B4E3-35973805644CQ39427409-BF4FD55B-03F5-4DB4-A37D-3A4EC660462BQ40379709-E73DD687-2553-4AA0-8AD8-BD424377D678Q47327411-4A85D0DA-C7A8-4914-9246-2214794F010FQ49904653-36D73980-F940-41F7-9497-C0C699679D67Q51161134-29E8D67D-C24B-44E3-82B8-D1F906FAA84CQ55496723-6F328513-48C6-41C5-AC3B-234407BCB420
P2860
Sclerostin and Insulin Resistance in Prediabetes: Evidence of a Cross Talk Between Bone and Glucose Metabolism.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Sclerostin and Insulin Resista ...... n Bone and Glucose Metabolism.
@en
Sclerostin and Insulin Resista ...... n Bone and Glucose Metabolism.
@nl
type
label
Sclerostin and Insulin Resista ...... n Bone and Glucose Metabolism.
@en
Sclerostin and Insulin Resista ...... n Bone and Glucose Metabolism.
@nl
prefLabel
Sclerostin and Insulin Resista ...... n Bone and Glucose Metabolism.
@en
Sclerostin and Insulin Resista ...... n Bone and Glucose Metabolism.
@nl
P2093
P356
P1433
P1476
Sclerostin and Insulin Resista ...... en Bone and Glucose Metabolism
@en
P2093
Andrea Mari
Christopher Jenkinson
Deidre Winnier
Devjit Tripathy
Jan Bruder
Marcel Fourcaudot
Zuo Pengou
P304
P356
10.2337/DC14-2989
P407
P577
2015-06-17T00:00:00Z